Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

A randomized phase II study of paclitaxel (P), carboplatin (C), bevacizumab (B) +/- everolimus (E) in metastatic melanoma (MM): secondary analysis of outcomes in patients who harbor an NRAS mutation NCCTG N0879 (Alliance).

Kottschade, Lisa , Allred, Jacob , Rumila, K. , Markovic, Svetomir ... - SMR - - 2017

Abstract - Secondary - Primary - Experimental - NCCTG-N0879

Cell Free DNA BRAF Mutation V600 Plasma Detection in Melanoma (Alliance) NCCTG N0879

Slostad, Jessica , Allred, Jake , Markovic, Svetomir , Erickson, Lori ... - SMR - Pigment Cell & Melanoma Research - 2018

Abstract - Secondary - Primary - Correl Sci NOS - NCCTG-N0879